Engineered 3D ex vivo models to recapitulate the complex stromal and immune interactions within the tumor microenvironment
Biomaterials. 2023 Dec 19;305:122428. doi: 10.1016/j.biomaterials.2023.122428. Online ahead of print.ABSTRACTCancer thrives in a complex environment where interactions between cellular and acellular components, surrounding the tumor, play a crucial role in disease development and progression. Despite significant progress in cancer research, the mechanism driving tumor growth and therapeutic outcomes remains elusive. Two-dimensional (2D) cell culture assays and in vivo animal models are commonly used in cancer research and therapeutic testing. However, these models suffer from numerous shortcomings including lack of key features of the tumor microenvironment (TME) & cellular composition, cost, and ethical clearance. To that end, there is an increased interest in incorporating and elucidating the influence of TME on cancer progression. Advancements in 3D-engineered ex vivo models, leveraging biomaterials and microengineering technologies, have provided an unprecedented ability to reconstruct native-like bioengineered cancer models to study the heterotypic interactions of TME with a spatiotemporal organization. These bioengineered cancer models have shown excellent capabilities to bridge the gap between oversimplified 2D systems and animal models. In this review article, we primarily provide an overview of the immune and stromal cellular components of the TME and then discuss the latest state-of-the-art 3D-engineered ex vivo platforms aiming to recapitulate the complex TME f...
Source: Biomaterials - Category: Materials Science Authors: Kalpana Ravi Twinkle Jina Minette Manoharan Kuei-Chun Wang Barbara Pockaj Mehdi Nikkhah Source Type: research
More News: Cancer | Cancer & Oncology | Environmental Health | Materials Science | Medical Ethics | Study